NCCN Guidelines for Patients® | Mantle Cell Lymphoma

23 NCCN Guidelines for Patients ® : Mantle Cell Lymphoma, 2019 3  Treatment guide Overview † † Stable disease is no clear change in the cancer. † † Progressive disease is a worsening of the cancer. Follow-up care If there’s a complete response, you may start follow- up care when initial treatment ends. This care may include a medical history, physical exam, imaging, and blood tests. See your doctor every 3 to 6 months for 5 years or when needed. After 5 years of normal results, see your doctor every year or as needed. Second-line treatment Doctors give second-line treatment for a few reasons. It is sometimes used to achieve a complete response if a partial response was attained. Likewise, it may also be given if the cancer is stable or progresses during initial treatment (also called refractory disease). A third reason for second-line treatment is to treat cancer that returns after a complete response. The return of cancer is called a relapse. Supportive care Cancer and its treatment may cause health problems. You may be treated to prevent or control these health problems. This treatment is a part of supportive care. Work with your doctor to create a supportive care plan that is best for you. My first chemo was rather harsh. The second chemo was so much easier. That is the progress of newer, better chemo drugs.” – Scott Survivor, relapsed at age 60 “